CLINICAL_TRIALS
trial_result
· 2012-11-21
Clinical Trial Update: An Efficacy and Safety Study of CNTO 1275 Compared to Etanercept in Patients With Plaque Psoriasis [Phase 3]
Summary
A Phase 3 trial compares CNTO 1275 (ustekinumab) to etanercept to evaluate efficacy and safety in adults with plaque psoriasis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Centocor, Inc. | Conditions: Psoriasis | Phase 3 | Status: COMPLETED | Results posted: 2012-11-21